Medtronic, Inc. Sued in Off-label Stents Case

Bookmark and Share

Mass Device -- Medtronic Inc. joins medical device industry peers Boston Scientific, Johnson & Johnson and Abbott in being accused in a whistleblower lawsuit accusing it of deliberately promoting the off-label use of biliary stents to treat cardiovascular conditions.
MORE ON THIS TOPIC